A value investing podcast. Antipodes is an active global equities investment manager, with offices in Sydney and London. Hear from the Antipodes team and other external thought leaders as they deliver investment updates and share perspectives on companies, macroeconomic trends and investment opportunities across the globe.
Episodes
7 days ago
7 days ago
Alison Savas interviews James Rodda, Lead Portfolio Manager of the Antipodes Global SMIDs Fund, to explore why global small and mid-cap stocks (SMIDs) present powerful, under-appreciated alpha opportunities.
They unpack the valuation gap between SMIDs and large caps, and how Antipodes’ strong investment platform and industry-led research approach provides a unique edge in identifying mis-priced opportunities.
A must-listen for anyone considering allocating to global SMIDs.
Key times:
Why Antipodes launched a global SMIDs Fund: 0:45
Why investors should consider an allocation to global SMIDs: 3:00
The importance of industry-led research & discussion about investing in Roku Inc (NASDAQ: ROKU): 08:00
Antipodes gobal SMID Fund performance: 18:00
Why Brookdale Senior Living Inc (NYSE: BKD) is one of the Fund's largest positions: 24:50
Stock commentary is illustrative only. Not recommendations to buy, hold, or sell any security.
No comments yet. Be the first to say something!